Caicun Zhou
- LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M+) advanced adenocarcinoma of the lungBy Yi-Long Wu, Caicun Zhou, Cheng-Ping Hu, Jifeng Feng, Shun Lu, Yunchao Huang, Wei Li, Mei Hou, Jian Hua Shi, Kye Young Lee, Dan Massey, Yang Shi, JiongJie Jack Chen, Victoria Zazulina and Sarayut L. GeaterYi-Long Wu1Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, ChinaCaicun Zhou2Department of Oncology, Shanghai Pulmonary Hospital, Shanghai, Yangpu District, ChinaCheng-Ping Hu3Department of Pulmonary Medicine, Xiangya Hospital, Central South University, Changsha, ChinaJifeng Feng4Department of Medical Oncology, Jiangsu Provincial Cancer Hospital, Nanjing, Jiangsu, ChinaShun Lu5Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, ChinaYunchao Huang6Department of Thoracic Surgery, Yunnan Tumor Hospital (The Third Affiliated Hospital of Kunming Medical University), Kunming, Yunnan Province, ChinaWei Li7Cancer Center, First Hospital of Jilin University, Changchun, ChinaMei Hou8West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaJian Hua Shi9Lin Yi Tumor Hospital, Linyi, Shandong Province, ChinaKye Young Lee10Lung Cancer Center, Konkuk University Medical Center, Seoul, KoreaDan Massey11Boehringer Ingelheim Limited, Bracknell, United KingdomYang Shi12Boehringer Ingelheim Int'l Trading (Shanghai) Co., Ltd., Shanghai, ChinaJiongJie Jack Chen12Boehringer Ingelheim Int'l Trading (Shanghai) Co., Ltd., Shanghai, ChinaVictoria Zazulina11Boehringer Ingelheim Limited, Bracknell, United KingdomSarayut L. Geater13Division of Respiratory and Respiratory Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
- Analysis of overall survival (OS) in two large open-label phase III studies (LUX-Lung 3 [LL3] and LUX-Lung 6 [LL6]) comparing afatinib with chemotherapy (CT) in patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring common (Del19/L858R) epidermal growth factor receptor mutations (EGFR mut)By Martin Sebastian, James Chih-Hsin Yang, Lecia Sequist, Martin Schuler, Tony Mok, Nobuyuki Yamamoto, Kenneth O'Byrne, Vera Hirsh, Sarayut Geater, Caicun Zhou, Dan Massey, Victoria Zazulina and Yi-Long WuMartin Sebastian1Department of Medicine, Hematology and Oncology, University of Frankfurt, Frankfurt, GermanyJames Chih-Hsin Yang2Department of Oncology, National Taiwan University Hospital, Taipei, TaiwanLecia Sequist3Department of Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA,Martin Schuler4West German Cancer Center, University Hospital Essen, Essen, GermanyTony Mok5Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, ChinaNobuyuki Yamamoto6Third Department of Internal Medicine, Wakayama Medical University, Wakayama, JapanKenneth O'Byrne7Oncology, St James' Hospital, Dublin, IrelandVera Hirsh8Oncology, McGill University, Montreal, CanadaSarayut Geater9Oncology, Prince of Songkla University, Songkla, ThailandCaicun Zhou10Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaDan Massey11Oncology, Boehringer Ingelheim Ltd, Bracknell, Berkshire, United KingdomVictoria Zazulina11Oncology, Boehringer Ingelheim Ltd, Bracknell, Berkshire, United KingdomYi-Long Wu12Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Guangzhou, China
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.